Filed with the SEC on · Summarized by InvestorsBot
Gilead Sciences Chairman and CEO, and director, Daniel Patrick O'Day sold 30,881 shares in six open-market transactions at prices ranging from $167.40 to $175.25 per share, for approximately $5.33 million. He owned 551,683 shares after the final sale.
Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.
Subscribe freeGilead raises 2026 revenue outlook after third-quarter sales growth
8-K · October 29, 2026
Gilead CEO Daniel O'Day sells $2.2M in stock
Form 4 · Insider Trade · October 2, 2026
Gilead CEO Daniel O'Day sells $2.2M in stock
Form 4 · Insider Trade · September 2, 2026
Gilead director Anthony Welters sells $2.7M in stock
Form 4 · Insider Trade · August 27, 2026
Gilead chief communications officer sells $3.85M in stock
Form 4 · Insider Trade · August 18, 2026
Gilead reports 10% revenue growth but widens 2026 loss guidance
8-K · August 4, 2026